Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease

Current Pharmaceutical Design

Volumn 14, Issue 26, 2008, Pages 2672-2677

  Balistreri, C R ^a   Grimaldi, M P ^a   Chiappelli, M ^a,b   Licastro, F ^b   Castiglia, L ^a   Listi, F ^a   Vasto, S ^a   Lio, D ^a   Caruso, C ^a   Candore, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alzheimer's disease; CD14; Inflammation; Innate immunity; TLR4

Indexed keywords

CD14 ANTIGEN; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ALZHEIMER DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INFLAMMATION; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD14; FEMALE; HUMANS; INFLAMMATION; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 4;

EID: 57349160857     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786264089     Document Type: Review

References (50)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005; 366: 2112-17.
2. Blennow K, de Leon M, Zetterberg H. Alzheimer's disease. Lancet 2006; 308: 387-403.
3. Akiyama S, Barger S, Barnum B, Bradt J, Bauer GM, Cole NR, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421.
4. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C et al. Innate immunity and inflammation in ageing: A key for understanding age-related diseases. Immun Ageing 2005; 2: 8.
5. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2002; 40: 260-69
6. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004; 77: 1-8.
7. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002; 40: 232-9.
8. Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the brain diseases. Curr Med Chem 2007; 14: 1189-97.
9. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem 2007; 20: 947-56.
10. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61: 1013-21.
11. Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T, et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004; 1: 203-5.
12. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide- induced oligodendrocyte injury in the CNS. J Neurosci 2002; 22: 2478-86.
13. Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W, et al. LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 2005; 128 (Pt 8): 1778-89.
14. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004; 173: 3916-24.
15. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514-9.
16. Cacabelos R, Fernandez-Novoa L, Lombardi V, Kubota Y, Takeda M. Molecular genetics of Alzheimer's disease and aging. Methods Find Exp Clin Pharmacol 2005; 27(Suppl A): 1-573.
17. Bird T.D. Genetic factors in Alzheimer's disease. N Engl J Med 2005; 352: 862-4.
18. Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C, et al. Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis. Brain Res Rev 2008; Epub ahead of print.
19. Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, et al. Gene polymorphism affecting alpha-1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol 2000; 48: 388-91.
20. Licastro F, Chiappelli M, Grimaldi LM, Morgan K, Kalsheker N, Calabrese E, et al. A new promoter polymorphism in the alpha-1- antichymotrypsin gene is a disease modifier of Alzheimer's disease. Neurobiol Aging 2005; 26: 449-53.
21. Lio D, Annoni G, Licastro F, Crivello A, Forte GI, Scola L, et al. Tumor necrosis factor-alpha-308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev 2006; 127: 567-71.
22. Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L. Association between the interleukin-1alpha gene and Alzheimer's disease: A meta-analysis. Neurobiol Aging 2004; 25: 1293-1308.
23. Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, et al. Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 2005; 26: 455-64.
24. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 2003; 4: 234-8.
25. Vasto S, Candore G, Listi F, Balistreri CR, Colonna-Romano G, Malavolta M, et al. Inflammation, genes and zinc in Alzheimer's disease. Brain Res Rev 2008; 58: 96-105.
26. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-91.
27. Balistreri CR, Candore G, Colonna-Romano G, Grimaldi MP, Lio D, Listi F, et al. Role of TLR polymorphisms in immunosenescence. Sprinter Book 2008; in press.
28. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167: 5838-44.
29. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, et al. C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218-20.
30. Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau CA. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol 2002; 249: 821-3.
31. Combarros O, Infante J, Rodriguez E, Llorca J, Pena N, Fernandez-Viadero C, et al. CD14 receptor polymorphism and Alzheimer's disease risk. Neurosci Lett 2005; 380: 193-6.
32. Rodríguez-Rodríguez E, Sánchez-Juan P, Mateo I, Infante J, Sanchez-Quintana C, Garcia-Gorostiaga I, et al. Interaction between CD14 and LXRbeta genes modulates Alzheimer's disease risk. J Neurol Sci 2008; 264: 97-9.
33. Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E, et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 2006; 391: 147-9.
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-III-R. 3rd revisMd ed. Washington (DC):American Psychiatric Association 1987.
36. Balistreri CR, Candore G, Lio D, Colonna-Romano G, Di Lorenzo G, Mansueto P, et al. Role of TLR4 receptor polymorphisms in Boutonneuse fever. Int J Immunopathol Pharmacol 2005; 18: 655-60.
37. Candore G, Balistreri CR, Grimaldi MP, et al. Age-related inflammatory diseases: Role of the genetics and gender in the pathophysiology of Alzheimer's disease. Ann NY Acad Sci 2006; 1089: 472-86.
38. McGeer EG, McGeer PL. Innate immunity in Alzheimer's disease: A model for local inflammatory reactions. Mol Interv 2001; 1: 22-9.
39. Lotz M, Ebert S, Esselmann H, Iliev AI, Prinz M, Wiazewicz N, et al. Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9- induced inflammation in primary mouse microglial cell cultures. J Neurochem 2005; 94: 289-98.
40. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and toll-like receptor 4: A link between infection and acute coronary events? Heart 2004; 90: 983-8.
41. Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, Hoffmann E, et al. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004; 292: 2339-40.
42. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002; 52: 168-74.
43. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003; 74: 788-9.
44. Crentsil V. The pharmacogenomics of Alzheimer's disease. Ageing Res Rev 2004; 3: 153-69.
45. Candore G, Balistreri CR, Grimaldi MP, Listi F, Vasto S, Chiappelli M, et al. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: A pharmacogenomic approach. Mech Ageing Dev 2007; 128: 67-75.
46. Vasto S, Candore G, Duro G, Lio D, Grimaldi MP, Caruso C. Alzheimer's disease and genetics of inflammation: A pharmacogenomic vision. Pharmacogenomics 2007; 8: 1735-45.
47. Tobinick EL, Gross H. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflamm 2008; 5: 2.
48. Hoozemans JJ, Rozemuller JM, van Haastert ES, Veerhuis R, Eikelenboom P. Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology. Curr Pharm Des 2008; 14(14): 1419-27.
49. Joyee AG, Yang X. Role of toll-like receptors in immune responses to chlamydial infections. Curr Pharm Des 2008; 14(6): 593-600.
50. Terahara K, Takahashi KG. Mechanisms and immunological roles of apoptosis in molluscs. Curr Pharm Des 2008; 14(2): 131-7.